Payment overview · 2025
General Payments
$29.24
2 reported records · 2 companies
Healthcare provider profile · identity verified
Jayesh J Patel, MD
Allopathic & Osteopathic Physicians|Internal Medicine · FAIRFIELD, CA · NPI 1427079169
Verified facts
What the public records show
CMS Open Payments records show Jayesh J Patel, MD received $29.24 in general payments during 2025 across 2 reported records.
Regeneron Healthcare Solutions, Inc. accounted for 53.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | Unresolved — no canonical attribution shown | $15.72 | 53.8% | 1 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $13.52 | 46.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $29.24 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| DUPIXENT Normalized: dupixent |
Biological | Regeneron Healthcare Solutions, Inc. | $15.72 | 1 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $13.52 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 506 | 135 |
| Levothyroxine Sodium | Levothyroxine Sodium | 362 | 87 |
| Amlodipine Besylate | Amlodipine Besylate | 353 | 99 |
| Lisinopril | Lisinopril | 295 | 91 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 290 | 28 |
| Metformin Hcl | Metformin Hcl | 275 | 76 |
| Losartan Potassium | Losartan Potassium | 266 | 72 |
| Simvastatin | Simvastatin | 262 | 72 |
| Omeprazole | Omeprazole | 233 | 63 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 225 | 53 |
| Diclofenac Sodium | Diclofenac Sodium | 215 | 52 |
| Gabapentin | Gabapentin | 215 | 68 |
| Hydrochlorothiazide | Hydrochlorothiazide | 185 | 57 |
| Pantoprazole Sodium | Pantoprazole Sodium | 182 | 59 |
| Fluticasone Propionate | Fluticasone Propionate | 167 | 56 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 158 | 51 |
| Metoprolol Succinate | Metoprolol Succinate | 140 | 43 |
| Baclofen | Baclofen | 132 | 42 |
| Glimepiride | Glimepiride | 123 | 33 |
| Ibuprofen | Ibuprofen | 117 | 35 |
| Allopurinol | Allopurinol | 114 | 26 |
| Metoprolol Tartrate | Metoprolol Tartrate | 112 | 32 |
| Clopidogrel | Clopidogrel Bisulfate | 102 | 29 |
| Tizanidine Hcl | Tizanidine Hcl | 102 | 26 |
| Furosemide | Furosemide | 99 | 24 |
| Carvedilol | Carvedilol | 95 | 26 |
| Tamsulosin Hcl | Tamsulosin Hcl | 93 | 33 |
| Hydralazine Hcl | Hydralazine Hcl | 92 | 26 |
| Potassium Chloride | Potassium Chloride | 88 | 22 |
| Famotidine | Famotidine | 86 | 24 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 84 | 15 |
| Atenolol | Atenolol | 83 | 23 |
| Ketoconazole | Ketoconazole | 82 | 21 |
| Trazodone Hcl | Trazodone Hcl | 82 | 23 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 79 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 75 | 29 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 70 | 25 |
| Tramadol Hcl | Tramadol Hcl | 66 | suppressed |
| Eliquis | Apixaban | 63 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 61 | 15 |
| Ozempic | Semaglutide | 57 | 12 |
| Glipizide | Glipizide | 55 | 19 |
| Meloxicam | Meloxicam | 49 | 18 |
| Alendronate Sodium | Alendronate Sodium | 47 | 12 |
| Montelukast Sodium | Montelukast Sodium | 47 | suppressed |
| Irbesartan | Irbesartan | 46 | 11 |
| Ezetimibe | Ezetimibe | 45 | 15 |
| Buspirone Hcl | Buspirone Hcl | 42 | suppressed |
| Januvia | Sitagliptin Phosphate | 42 | 14 |
| Amitriptyline Hcl | Amitriptyline Hcl | 41 | suppressed |
| Trulicity | Dulaglutide | 41 | suppressed |
| Alprazolam | Alprazolam | 40 | suppressed |
| Digoxin | Digoxin | 39 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 39 | 14 |
| Spironolactone | Spironolactone | 39 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 38 | 11 |
| Clonidine Hcl | Clonidine Hcl | 37 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 37 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 36 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 36 | 13 |
| Meclizine Hcl | Meclizine Hcl | 36 | 15 |
| Pregabalin | Pregabalin | 36 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 34 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 33 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 32 | suppressed |
| Levetiracetam | Levetiracetam | 32 | suppressed |
| Cephalexin | Cephalexin | 31 | 21 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 31 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 29 | 25 |
| Lovastatin | Lovastatin | 29 | suppressed |
| Naproxen | Naproxen | 29 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 29 | 24 |
| Jardiance | Empagliflozin | 28 | suppressed |
| Finasteride | Finasteride | 27 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 27 | suppressed |
| Olanzapine | Olanzapine | 27 | suppressed |
| Carisoprodol | Carisoprodol | 26 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 26 | 14 |
| Donepezil Hcl | Donepezil Hcl | 26 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 26 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 26 | suppressed |
| Acyclovir | Acyclovir | 25 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 25 | suppressed |
| Ativan | Lorazepam | 24 | suppressed |
| Lorazepam | Lorazepam | 24 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 24 | suppressed |
| Sulindac | Sulindac | 24 | suppressed |
| Xarelto | Rivaroxaban | 24 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 23 | suppressed |
| Lidocaine | Lidocaine | 23 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 23 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 22 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 22 | suppressed |
| Tradjenta | Linagliptin | 22 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 20 | suppressed |
| Telmisartan | Telmisartan | 20 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 20 | suppressed |
| Bumetanide | Bumetanide | 19 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 19 | suppressed |
| Celecoxib | Celecoxib | 19 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 18 | suppressed |
| Fenofibrate | Fenofibrate | 18 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 18 | suppressed |
| Mirtazapine | Mirtazapine | 18 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 18 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 18 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 18 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 17 | suppressed |
| Methadone Hcl | Methadone Hcl | 17 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 17 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 17 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 16 | suppressed |
| Azithromycin | Azithromycin | 16 | suppressed |
| Diazepam | Diazepam | 16 | suppressed |
| Humulin R | Insulin Regular, Human | 16 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Lactulose | Lactulose | 14 | suppressed |
| Lamotrigine | Lamotrigine | 14 | suppressed |
| Linzess | Linaclotide | 14 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Prednisone | Prednisone | 14 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Amoxicillin | Amoxicillin | 13 | suppressed |
| Bupropion Xl | Bupropion Hcl | 13 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 13 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 13 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 13 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 13 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 13 |
| Prazosin Hcl | Prazosin Hcl | 13 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 13 | suppressed |
| Desloratadine | Desloratadine | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Glipizide Er | Glipizide | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Procto-Med Hc | Hydrocortisone | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 12 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 11 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Lansoprazole | Lansoprazole | 11 | suppressed |
| Loperamide | Loperamide Hcl | 11 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 11 | suppressed |
| Ondansetron Odt | Ondansetron | 11 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 11 | suppressed |
| Primidone | Primidone | 11 | suppressed |
| Sucralfate | Sucralfate | 11 | suppressed |
| Xifaxan | Rifaximin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $29.24 · 2 records | Regeneron Healthcare Solutions, Inc. | AIRSUPRA, DUPIXENT | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error